Search

everythinglearnresearchcommunity

for

Search:↓

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Isotretinoin can cause serious birth defects and needs careful use, especially in pregnant women.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

New treatments for PCOS focus on managing symptoms and improving fertility.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Testosterone is crucial for development, growth, and various body functions in mammals.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

The document suggests changing medical education to balance generalists and specialists, focusing on patient needs.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Women with PCOS have more emotional and body image issues than healthy women.

In 2020, a new online survey was made to help identify Polycystic ovary syndrome (PCOS) in women, but it needs some improvements for better understanding and accuracy.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

PCOS is a common hormonal disorder in women that can affect skin, fertility, and metabolism, and treatment is tailored to individual needs.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Preparing and learning about menopause can improve women's quality of life as they approach this phase.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

Women with PCOS have higher risks of heart disease, type 2 diabetes, and endometrial cancer.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.